Effect of Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure Patients With Hepatic Encephalopathy
Phase of Trial: Phase II
Latest Information Update: 04 Feb 2017
At a glance
- Drugs Rifaximin (Primary) ; Lactulose
- Indications Hepatic encephalopathy; Liver failure
- Focus Therapeutic Use
- 15 Feb 2016 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 05 Jan 2016 Planned End Date changed from 1 Oct 2016 to 1 Jan 2016 as reported by ClinicalTrials.gov record.
- 05 Jan 2016 Planned primary completion date changed from 1 Oct 2015 to 1 Jan 2016.